Mainz Biomed (MYNZ) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MYNZ Mainz Biomed

Watchlist

0.247
+0.033+15.47%

Close Sep 27 16:00 ET

0.255
+0.008+3.16%

Post 19:59 ET

5.41MMarket Cap-152P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga12:31 ET
Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
Mainz BiomedSep 18 00:00 ET
Mainz Biomed Partners With Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
GlobeNewswireSep 4 04:01 ET
Express News | Mainz Biomed Launches Improvements To ColoAlert
BenzingaJul 25 08:11 ET
Mainz Biomed Launches Enhanced ColoAlert With Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
Mainz BiomedJul 25 00:00 ET
Mainz BioMed Seeks FDA Breakthrough Device Designation for Advanced Colorectal Cancer Test | NASDAQ:MYNZ
Proactive InvestorsJul 19 07:20 ET

Comments

Volatility Rider

Sep 18 13:48

The first rate cut has been determined by the Federal Reserve

$Mainz Biomed (MYNZ.US)$
Guys , the rate cut has already been confirmed. I suggest you hold your stock instead of selling them cheap

Aggressive 50bp rate cut: How long will the market frenzy last?

hasan hasan2

Sep 9 03:34

$Mainz Biomed (MYNZ.US)$ presents a significant opportunity for substantial profits, driven by several key catalysts. First, we anticipate an upcoming announcement regarding FDA clearance for a breakthrough device, followed by FDA approval within the next 30 days. This is an opportune moment to consider purchasing shares.

BuyLSellH

Sep 4 19:17

$Mainz Biomed (MYNZ.US)$ Companies that have partnered or collaborated with Mainz Biomed till the latest update:
1. **GANZIMMUN Diagnostics** (Germany) – Commercialization and distribution of ColoAlert [oai_citation:6,Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy - Mainz Biomed](https://mainzbiomed.com/mainz-biomed-establishes-strategic-partnership-with-tomalab-to-expand-availability-of-coloalert-in-italy/).
2. **testDNA Laboratory** (P...

BuyLSellH

Sep 4 19:12

$Mainz Biomed (MYNZ.US)$ Mainz Biomed’s **next-generation multimodal screening test** has been under development and recently made significant progress. The test has shown strong performance in various clinical trials, including **ColoFuture** and **eAArly Detect** studies. It integrates the **Fecal Immunochemical Test (FIT)** with proprietary **mRNA biomarkers** and advanced **AI/machine learning** algorithms, offering a more comprehensive approach to colorectal cancer screening [oai_citation:10...

Trytosaveabit

Sep 4 03:03

Hmm

$Mainz Biomed (MYNZ.US)$ Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
2 minutes ago, 4:01 AM EDT
Via GlobeNewswire

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

MYNZ Mainz Biomed

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target